| Medulloblastoma comprises four distinct molecular variants PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ... Journal of clinical oncology 29 (11), 1408-1414, 2011 | 1541 | 2011 |
| Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 MJ Van Den Bent, AA Brandes, MJB Taphoorn, JM Kros, ... Journal of clinical oncology 31 (3), 344-350, 2013 | 1299 | 2013 |
| EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ... Nature reviews Clinical oncology 18 (3), 170-186, 2021 | 1199 | 2021 |
| Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 1076 | 2017 |
| A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories MW Jones, ML Errington, PJ French, A Fine, TVP Bliss, S Garel, ... Nature neuroscience 4 (3), 289-296, 2001 | 1055 | 2001 |
| European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ... The lancet oncology 18 (6), e315-e329, 2017 | 1008 | 2017 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 969 | 2012 |
| Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology LAM Gravendeel, MCM Kouwenhoven, O Gevaert, JJ de Rooi, AP Stubbs, ... Cancer research 69 (23), 9065-9072, 2009 | 682 | 2009 |
| Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome TC Pansuriya, R van Eijk, P d'Adamo, MAJH van Ruler, ML Kuijjer, ... Nature genetics 43 (12), 1256-1261, 2011 | 573 | 2011 |
| Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ... Journal of Clinical Oncology 31 (23), 2927-2935, 2013 | 516 | 2013 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 414 | 2019 |
| Novel, improved grading system (s) for IDH-mutant astrocytic gliomas M Shirahata, T Ono, D Stichel, D Schrimpf, DE Reuss, F Sahm, ... Acta neuropathologica 136, 153-166, 2018 | 389 | 2018 |
| Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ... The lancet oncology 17 (4), 484-495, 2016 | 367 | 2016 |
| Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886-896, 2014 | 358 | 2014 |
| Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines A Hollestelle, JHA Nagel, M Smid, S Lam, F Elstrodt, M Wasielewski, ... Breast cancer research and treatment 121 (1), 53-64, 2010 | 348 | 2010 |
| A mouse model for the cystic fibrosis delta F508 mutation. JH Van Doorninck, PJ French, E Verbeek, RH Peters, H Morreau, ... The EMBO journal 14 (18), 4403-4411, 1995 | 301 | 1995 |
| The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis MMJ Wijnenga, PJ French, HJ Dubbink, WNM Dinjens, PN Atmodimedjo, ... Neuro-oncology 20 (1), 103-112, 2018 | 294 | 2018 |
| Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? NK Kloosterhof, LBC Bralten, HJ Dubbink, PJ French, MJ van den Bent The lancet oncology 12 (1), 83-91, 2011 | 266 | 2011 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 216 | 2022 |
| Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 … MJ van den Bent, CMS Tesileanu, W Wick, M Sanson, AA Brandes, ... The Lancet Oncology 22 (6), 813-823, 2021 | 199 | 2021 |
